BAX
Baxter International Inc.

2,607
Mkt Cap
$9.49B
Volume
11.56M
52W High
$37.74
52W Low
$18.42
PE Ratio
-29.39
BAX Fundamentals
Price
$18.47
Prev Close
$19.16
Open
$18.81
50D MA
$23.14
Beta
0.76
Avg. Volume
6.71M
EPS (Annual)
-$1.27
P/B
1.30
Rev/Employee
$279,894.74
Loading...
Loading...
News
all
press releases
Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action - BAX
Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action - BAX Investors who lost money on Baxter International, Inc.(BAX) should contact...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
Baxter Stock Logs Worst Day In 3 Months On Margin Pain And Weak Guidance — Retail Sees Long-Term Buy Opportunity
The company cut its 2025 EPS and sales forecasts and announced a dividend reduction starting January 2026 to accelerate debt repayment.
Stocktwits·3d ago
News Placeholder
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
Business Wire·3d ago
News Placeholder
Here's What Key Metrics Tell Us About Baxter (BAX) Q3 Earnings
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·3d ago
News Placeholder
BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down
Baxter's Q3 earnings top forecasts, but sales lag and 2025 EPS guidance slips; shares fall despite strength in Pharma and Advanced Surgery.
Zacks·3d ago
News Placeholder
Investors in Baxter International, Inc. Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX
Investors in Baxter International, Inc. Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX Investors in Baxter International, Inc. Should Contact The Gross Law...
PR Newswire·3d ago
News Placeholder
Baxter International (BAX) Beats Q3 Earnings Estimates
Baxter (BAX) delivered earnings and revenue surprises of +15.00% and -1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Baxter Reports Third-Quarter 2025 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025. I joined Baxter because its a global healthcare leader an iconic brand with an...
Business Wire·3d ago
News Placeholder
BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit BAX INVESTOR NOTICE...
PR Newswire·4d ago
News Placeholder
Deadline Approaching: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Baxter...
Business Wire·4d ago

Latest BAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.